Particulars |
|
|
|
Company Name
| Aurobindo Pharma Ltd
| Year End
| 202403
|
Full Year |
Equity (₹ Cr.) |
58.59 |
B.V. (₹) |
336.60 |
Sales(₹ Cr.) |
10,542.21 |
NP (₹ Cr.) |
1,900.10 |
NP Var (%) |
56.00 |
Div% |
150.00 |
CPS(₹) |
36.80 |
EPS (₹) |
32.40 |
Traded Value(₹ Lakhs) |
192.84 |
52 Week High |
1,409.00 |
52 Week Low |
792.00 |
Price BSE |
1,386.00 |
Price NSE |
1,386.00 |
Market Capital (₹ Cr.) |
81,228.67 |
P/C Ratio |
37.70 |
P/E Ratio |
42.70 |
Price Vs.BV |
4.12 |
|
Latest Quarter |
Year End |
202403 |
Sales (₹ Cr.) |
2,866.40 |
NP(₹ Cr.) |
578.67 |
NP Var % |
-3.00 |
Trailing Twelve Months |
Year End |
202403 |
Sales |
11,197.53 |
OPM |
10.11 |
NP |
1,400.90 |
NP Var (%) |
55.69 |
EPS |
32.43 |
PE |
42.75 |
|
|